VitusCare raises $3M Series B for hospital dialysis model
Dialysis provider VitusCare secured $3 million in Series B financing with backing from Liberty Ridge Capital, HDFC Bank, and Equentis.

Screenshot: vituscare.com
Healthcare provider VitusCare has raised $3 million in a Series B round backed by Liberty Ridge Capital, HDFC Bank, and Equentis, according to reporting from Enablers [1].
The healthtech company delivers specialized dialysis services through an asset-light framework [1]. Instead of constructing standalone clinics, VitusCare relies on a shop-in-shop approach that places its clinical operations directly inside existing partner hospitals [1]. The structure allows the business to offer kidney care treatments within host facilities while limiting upfront infrastructure expenditures [1].
Financing participants named in the round include investment firms Liberty Ridge Capital and Equentis, alongside Indian financial institution HDFC Bank [1]. The company did not specify a lead backer [1]. VitusCare has not disclosed its valuation, previous funding, or budget for the new capital [1].
Questions and answers
How much capital did VitusCare secure in its Series B round?
VitusCare raised $3 million in Series B funding.
Which investors backed the VitusCare financing?
Disclosed participants include Liberty Ridge Capital, HDFC Bank, and Equentis.
How does VitusCare deliver dialysis treatments?
VitusCare uses a shop-in-shop model that establishes specialized dialysis care units inside existing hospital centers.
Companies & investors in this story
Sources
- 1.VitusCare has raised USD 3 Million in a Series B funding round from Liberty Ridge Capital, HDFC Bank, Equentis, and others - Enablers — enablersinvestment.com
- 2.VitusCare raises $3 million in Series B funding — ETHealthWorld, Nov 19, 2026
